We design a new set of BRET biosensors based on the fluorescent properties of TC-domain/FlAsH-EDT2.
We use the TC domain to allow us to use BRET to measure conformational changes within the channel.
These changes allow us to measure dose response curves for channel agonists and δ-opioid receptor agonists.
The BRET responses we see can be compared to other measures of channel activation.